Indivior PLC (LON:INDV - Get Free Report) reached a new 52-week high on Thursday . The stock traded as high as £1,453 ($1,794.71) and last traded at GBX 1,425 ($17.60), with a volume of 782614 shares changing hands. The stock had previously closed at GBX 1,514 ($18.70).
Indivior Price Performance
The company has a current ratio of 0.97, a quick ratio of 1.52 and a debt-to-equity ratio of 240.17. The stock's 50-day moving average is GBX 1,620.30 and its two-hundred day moving average is GBX 1,443.59. The company has a market capitalization of £1.90 billion, a PE ratio of 140,400.00, a price-to-earnings-growth ratio of -5.57 and a beta of -0.05.
Insider Activity
In related news, insider Mark Crossley sold 10,549 shares of Indivior stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of GBX 1,617 ($19.97), for a total value of £170,577.33 ($210,693.34). Insiders own 3.21% of the company's stock.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Articles
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
